Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing ahmed glaucoma valve implantation: 2-year follow-up

Minwen Zhou^{1

2}, Jiawei Wang³, Xiaodong Sun^{1

2}

Affiliations

¹ Department of Ophthalmology, Shanghai First People's Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China.
² Shanghai Key Laboratory of Fundus Disease, Shanghai, China.
³ State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.

Free article

Comment

Minwen Zhou et al. Acta Ophthalmol. 2016 Feb.

Free article

. 2016 Feb;94(1):e78.

doi: 10.1111/aos.12608. Epub 2014 Dec 8.

Minwen Zhou^{1

2}, Jiawei Wang³, Xiaodong Sun^{1

2}

¹ Department of Ophthalmology, Shanghai First People's Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai, China.
² Shanghai Key Laboratory of Fundus Disease, Shanghai, China.
³ State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.

No abstract available

Comment on

Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
Arcieri ES, Paula JS, Jorge R, Barella KA, Arcieri RS, Secches DJ, Costa VP. Arcieri ES, et al. Acta Ophthalmol. 2015 Feb;93(1):e1-6. doi: 10.1111/aos.12493. Epub 2014 Jul 2. Acta Ophthalmol. 2015. PMID: 24989855 Clinical Trial.